Table of Contents Global Alzheimer’s Disease Therapeutics and Diagnostics Market Research Report 2021, Forecast to 2026 1 Market Study Overview 1.1 Study Objectives 1.2 Alzheimer’s Disease Therapeutics and Diagnostics Introduce 1.3 Combined with the Analysis of Macroeconomic Indicators 1.4 Brief Description of Research methods 1.5 Market Breakdown and Data Triangulation 2 Global Trend Summary 2.1 Alzheimer’s Disease Therapeutics and Diagnostics Segment by Type 2.1.1 Lumbar puncture test 2.1.2 Computed tomography (CT) scan 2.1.3 Magnetic resonance imaging (MRI) 2.1.4 Electroencephalography (EEG) 2.1.5 Positron emission tomography (PET) scan 2.1.6 Others 2.2 Market Analysis by Application 2.2.1 Marketed Drugs 2.2.2 Pipeline Drugs 2.3 Global Alzheimer’s Disease Therapeutics and Diagnostics Market Comparison by Regions (2016-2026) 2.3.1 Global Alzheimer’s Disease Therapeutics and Diagnostics Market Size (2016-2026) 2.3.2 North America Alzheimer’s Disease Therapeutics and Diagnostics Status and Prospect (2016-2026) 2.3.3 Europe Alzheimer’s Disease Therapeutics and Diagnostics Status and Prospect (2016-2026) 2.3.4 China Alzheimer’s Disease Therapeutics and Diagnostics Status and Prospect (2016-2026) 2.3.5 Japan Alzheimer’s Disease Therapeutics and Diagnostics Status and Prospect (2016-2026) 2.3.6 Southeast Asia Alzheimer’s Disease Therapeutics and Diagnostics Status and Prospect (2016-2026) 2.4 Basic Product Information 2.4.1 Basic Product Information & Technology Development History 2.4.2 Product Manufacturing Process 2.4.3 Interview with Major Market Participants 2.4.4 High-end Market Analysis and Forecast 2.5 Coronavirus Disease 2019 (Covid-19): Alzheimer’s Disease Therapeutics and Diagnostics Industry Impact 2.5.1 Alzheimer’s Disease Therapeutics and Diagnostics Business Impact Assessment - Covid-19 2.5.2 Market Trends and Alzheimer’s Disease Therapeutics and Diagnostics Potential Opportunities in the COVID-19 Landscape 2.5.3 Measures / Proposal against Covid-19 3 Competition by Manufacturer 3.1 Global Alzheimer’s Disease Therapeutics and Diagnostics Sales and Market Share by Manufacturer (2016-2021) 3.2 Global Alzheimer’s Disease Therapeutics and Diagnostics Revenue and Market Share by Manufacturer (2016-2021) 3.3 Global Alzheimer’s Disease Therapeutics and Diagnostics Industry Concentration Ratio (CR5 and HHI) 3.4 Top 5 Alzheimer’s Disease Therapeutics and Diagnostics Manufacturer Market Share 3.5 Top 10 Alzheimer’s Disease Therapeutics and Diagnostics Manufacturer Market Share 3.6 Date of Key Manufacturers Enter into Alzheimer’s Disease Therapeutics and Diagnostics Market 3.7 Key Manufacturers Alzheimer’s Disease Therapeutics and Diagnostics Key Manufacturers 3.8 Mergers & Acquisitions Planning 4 Analysis of Alzheimer’s Disease Therapeutics and Diagnostics Industry Key Manufacturers 4.1 Pfizer 4.1.1 Compan Detail 4.1.2 Pfizer Alzheimer’s Disease Therapeutics and Diagnostics Product Introduction, Application and Specification 4.1.3 Pfizer 136 Sales, Price, Cost, Gross Margin, and Revenue (2016-2021) 4.1.4 Main Business Overview 4.1.5 Pfizer News 4.2 Eisai 4.2.1 Compan Detail 4.2.2 Eisai Alzheimer’s Disease Therapeutics and Diagnostics Product Introduction, Application and Specification 4.2.3 Eisai Alzheimer’s Disease Therapeutics and Diagnostics Sales, Price, Cost, Gross Margin, and Revenue (2016-2021) 4.2.4 Main Business Overview 4.2.5 Pfizer News 4.3 Novartis 4.3.1 Compan Detail 4.3.2 Novartis Alzheimer’s Disease Therapeutics and Diagnostics Product Introduction, Application and Specification 4.3.3 Novartis Alzheimer’s Disease Therapeutics and Diagnostics Sales, Price, Cost, Gross Margin, and Revenue (2016-2021) 4.3.4 Main Business Overview 4.3.5 Novartis News 4.4 Forest Laboratories 4.4.1 Compan Detail 4.4.2 Forest Laboratories Alzheimer’s Disease Therapeutics and Diagnostics Product Introduction, Application and Specification 4.4.3 Forest Laboratories Alzheimer’s Disease Therapeutics and Diagnostics Sales, Price, Cost, Gross Margin, and Revenue (2016-2021) 4.4.4 Main Business Overview 4.4.5 Forest Laboratories News 4.5 TauRx Therapeutics 4.5.1 Compan Detail 4.5.2 Forest Laboratories Alzheimer’s Disease Therapeutics and Diagnostics Product Introduction, Application and Specification 4.5.3 TauRx Therapeutics Alzheimer’s Disease Therapeutics and Diagnostics Sales, Price, Cost, Gross Margin, and Revenue (2016-2021) 4.5.4 Main Business Overview 4.5.5 TauRx Therapeutics News 4.6 AC Immune 4.6.1 Compan Detail 4.6.2 AC Immune Alzheimer’s Disease Therapeutics and Diagnostics Product Introduction, Application and Specification 4.6.3 AC Immune Alzheimer’s Disease Therapeutics and Diagnostics Sales, Price, Cost, Gross Margin, and Revenue (2016-2021) 4.6.4 Main Business Overview 4.6.5 AC Immune News 4.7 Johnson & Johnson. 4.7.1 Compan Detail 4.7.2 Johnson & Johnson. Alzheimer’s Disease Therapeutics and Diagnostics Product Introduction, Application and Specification 4.7.3 Johnson & Johnson. Alzheimer’s Disease Therapeutics and Diagnostics Sales, Price, Cost, Gross Margin, and Revenue (2016-2021) 4.7.4 Main Business Overview 4.7.4 Main Business Overview 4.8 H. Lundbeck 4.8.1 Compan Detail 4.8.2 H. Lundbeck Alzheimer’s Disease Therapeutics and Diagnostics Product Introduction, Application and Specification 4.8.3 H. Lundbeck Alzheimer’s Disease Therapeutics and Diagnostics Sales, Price, Cost, Gross Margin, and Revenue (2016-2021) 4.8.4 Main Business Overview 4.8.5 H. Lundbeck News 5 Global Alzheimer’s Disease Therapeutics and Diagnostics Market Segment by Big Type 5.1 Global Alzheimer’s Disease Therapeutics and Diagnostics Revenue, Sales and Market Share by Big Type (2016-2021) 5.1.1 Global Alzheimer’s Disease Therapeutics and Diagnostics Sales and Market Share by Big Type (2016-2021) 5.1.2 Global Alzheimer’s Disease Therapeutics and Diagnostics Revenue and Market Share by Big Type (2016-2021) 5.2 Lumbar puncture test Sales Growth Rate and Price 5.2.1 Global Lumbar puncture test Sales Growth Rate (2016-2021) 5.2.2 Global Lumbar puncture test Price (2016-2021) 5.3 Computed tomography (CT) scan Sales Growth Rate and Price 5.3.1 Global Computed tomography (CT) scan Sales Growth Rate (2016-2021) 5.3.2 Global Computed tomography (CT) scan Price (2016-2021) 5.4 Magnetic resonance imaging (MRI) Sales Growth Rate and Price 5.4.1 Global Magnetic resonance imaging (MRI) Sales Growth Rate (2016-2021) 5.4.2 Global Magnetic resonance imaging (MRI) Price (2016-2021) 5.5 Electroencephalography (EEG) Sales Growth Rate and Price 5.5.1 Global Electroencephalography (EEG) Sales Growth Rate (2016-2021) 5.5.2 Global Electroencephalography (EEG) Price (2016-2021) 5.6 Positron emission tomography (PET) scan Sales Growth Rate and Price 5.6.1 Global Positron emission tomography (PET) scan Sales Growth Rate (2016-2021) 5.6.2 Global Positron emission tomography (PET) scan Price (2016-2021) 5.7 Others Sales Growth Rate and Price 5.7.1 Global Others Sales Growth Rate (2016-2021) 5.7.2 Global Others Price (2016-2021) 6 Global Alzheimer’s Disease Therapeutics and Diagnostics Market Segment by Big Application 6.1 Global Alzheimer’s Disease Therapeutics and Diagnostics Sales Market Share by Big Application (2016-2021) 6.2 Marketed Drugs Sales Growth Rate (2016-2021) 6.3 Pipeline Drugs Sales Growth Rate (2016-2021) 7 Global Alzheimer’s Disease Therapeutics and Diagnostics Forecast 7.1 Global Alzheimer’s Disease Therapeutics and Diagnostics Revenue, Sales and Growth Rate (2021-2026) 7.2 Alzheimer’s Disease Therapeutics and Diagnostics Market Forecast by Regions (2021-2026) 7.2.1 North America Alzheimer’s Disease Therapeutics and Diagnostics Market Forecast (2021-2026) 7.2.2 Europe Alzheimer’s Disease Therapeutics and Diagnostics Market Forecast (2021-2026) 7.2.3 China Alzheimer’s Disease Therapeutics and Diagnostics Market Forecast (2021-2026) 7.2.4 Japan Alzheimer’s Disease Therapeutics and Diagnostics Market Forecast (2021-2026) 7.2.5 Southeast Asia Alzheimer’s Disease Therapeutics and Diagnostics Market Forecast (2021-2026) 7.2.6 Other Regions Alzheimer’s Disease Therapeutics and Diagnostics Market Forecast (2021-2026) 7.3 Alzheimer’s Disease Therapeutics and Diagnostics Market Forecast by Type (2021-2026) 7.3.1 Global Alzheimer’s Disease Therapeutics and Diagnostics Sales Forecast by Type (2021-2026) 7.3.2 Global Alzheimer’s Disease Therapeutics and Diagnostics Market Share Forecast by Type (2021-2026) 7.4 Alzheimer’s Disease Therapeutics and Diagnostics Market Forecast by Application (2021-2026) 7.4.1 Global Alzheimer’s Disease Therapeutics and Diagnostics Sales Forecast by Application (2021-2026) 7.4.2 Global Alzheimer’s Disease Therapeutics and Diagnostics Market Share Forecast by Application (2021-2026) 8 Market Analysis 8.1.1 Market Overview 8.1.2 Market Opportunities 8.1.3 Market Risk 8.1.4 Market Driving Force 8.1.5 Porter's Five Forces Analysis 8.1.6 SWOT Analysis 9 Alzheimer’s Disease Therapeutics and Diagnostics Related Market Analysis 9.1 Upstream Analysis 9.1.1 Macro Analysis of Upstream Markets 9.1.2 Key Players in Upstream Markets 9.1.3 Upstream Market Trend Analysis 9.1.4 Alzheimer’s Disease Therapeutics and Diagnostics Manufacturing Cost Analysis 9.2 Downstream Market Analysis 9.2.1 Macro Analysis of Down Markets 9.2.2 Key Players in Down Markets 9.2.3 Downstream Market Trend Analysis 9.2.4 Sales Channel, Distributors, Traders and Dealers 10 Research Findings and Conclusion

List of Tables and Figures Figure Product Picture Alzheimer’s Disease Therapeutics and Diagnostics Figure Market Concentration Ratio and Market Maturity Analysis of Alzheimer’s Disease Therapeutics and Diagnostics Figure Bottom-up and Top-down Approaches for This Report Figure Part of Our External Database Figure Part of Our External Database Figure Key Executives Interviewed Table Global Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Big Type Figure Global Market Share of Alzheimer’s Disease Therapeutics and Diagnostics by Big Type in 2020 Figure Lumbar puncture test Picture (2016-2021) Figure Computed tomography (CT) scan Picture (2016-2021) Figure Magnetic resonance imaging (MRI) Picture (2016-2021) Figure Electroencephalography (EEG) Picture (2016-2021) Figure Positron emission tomography (PET) scan Picture (2016-2021) Global Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Big Application Table Global Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Application Figure Global Alzheimer’s Disease Therapeutics and Diagnostics Market Share by Big Application in 2020 Figure Marketed Drugs Picture Figure Pipeline Drugs Picture Table Global Alzheimer’s Disease Therapeutics and Diagnostics Comparison by Regions (M USD) （2016-2026） Figure Global Alzheimer’s Disease Therapeutics and Diagnostics Market Size (Million US$) (2016-2026) Figure North America Alzheimer’s Disease Therapeutics and Diagnostics Revenue (Million US$) Growth Rate (2016-2026) Figure Europe Alzheimer’s Disease Therapeutics and Diagnostics Revenue (Million US$) Growth Rate (2016-2026) Figure China Alzheimer’s Disease Therapeutics and Diagnostics Revenue (Million US$) Growth Rate (2016-2026) Figure Japan Alzheimer’s Disease Therapeutics and Diagnostics Revenue (Million US$) Growth Rate (2016-2026) Figure Southeast Asia Alzheimer’s Disease Therapeutics and Diagnostics Revenue (Million US$) Growth Rate (2016-2026) Table Business Impact Assessment - Covid-19 Table Market Trends and Alzheimer’s Disease Therapeutics and Diagnostics Potential Opportunities in the COVID-19 Landscape Table Measures / Proposal against Covid-19 Table Global Alzheimer’s Disease Therapeutics and Diagnostics Sales by Manufacturer (2016-2021) Figure Global Alzheimer’s Disease Therapeutics and Diagnostics Sales Market Share by Manufacturer in 2020 Table Global Alzheimer’s Disease Therapeutics and Diagnostics Revenue by Manufacturer (2016-2021) Figure Global Alzheimer’s Disease Therapeutics and Diagnostics Revenue Market Share by Manufacturer in 2020 Table Global Alzheimer’s Disease Therapeutics and Diagnostics Manufacturers Market Concentration Ratio (CR5 and HHI) Figure Top 5 Alzheimer’s Disease Therapeutics and Diagnostics Manufacturer (Revenue) Market Share in 2020 Figure Top 10 Alzheimer’s Disease Therapeutics and Diagnostics Manufacturer (Revenue) Market Share in 2020 Table Date of Key Manufacturers Enter into Alzheimer’s Disease Therapeutics and Diagnostics Market Table Key Manufacturers Alzheimer’s Disease Therapeutics and Diagnostics Product Type Table Mergers & Acquisitions Planning Table Pfizer Company Profile Table Alzheimer’s Disease Therapeutics and Diagnostics Product Introduction, Application and Specification of Pfizer Table Alzheimer’s Disease Therapeutics and Diagnostics Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company One 2016-2021 Table Company One Main Business Table Company One Recent Development Table Eisai Company Profile Table Alzheimer’s Disease Therapeutics and Diagnostics Product Introduction, Application and Specification of Eisai Table Alzheimer’s Disease Therapeutics and Diagnostics Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2016-2021 Table Eisai Recent Development Table Novartis Company Profile Table Alzheimer’s Disease Therapeutics and Diagnostics Product Introduction, Application and Specification of Novartis Table Alzheimer’s Disease Therapeutics and Diagnostics Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2016-2021 Table Novartis Main Business Table Novartis Recent Development Table Forest Laboratories Company Profile Table Alzheimer’s Disease Therapeutics and Diagnostics Product Introduction, Application and Specification of Forest Laboratories Table Alzheimer’s Disease Therapeutics and Diagnostics Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2016-2021 Table Forest Laboratories Main Business Table Forest Laboratories Recent Development Table Forest Laboratories Main Business Table Forest Laboratories Recent Development Table TauRx Therapeutics Company Profile Table Alzheimer’s Disease Therapeutics and Diagnostics Product Introduction, Application and Specification of TauRx Therapeutics Table Alzheimer’s Disease Therapeutics and Diagnostics Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2016-2021 Table TauRx Therapeutics Main Business Table TauRx Therapeutics Recent Development Table AC Immune Company Profile Table Alzheimer’s Disease Therapeutics and Diagnostics Product Introduction, Application and Specification of AC Immune Table Alzheimer’s Disease Therapeutics and Diagnostics Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2016-2021 Table AC Immune Main Business Table AC Immune Recent Development Table Johnson & Johnson. Company Profile Table Alzheimer’s Disease Therapeutics and Diagnostics Product Introduction, Application and Specification of Johnson & Johnson. Table Alzheimer’s Disease Therapeutics and Diagnostics Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2016-2021 Table Johnson & Johnson. Main Business Table Johnson & Johnson. Recent Development Table H. Lundbeck Company Profile Table Alzheimer’s Disease Therapeutics and Diagnostics Product Introduction, Application and Specification of H. Lundbeck Table Alzheimer’s Disease Therapeutics and Diagnostics Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2016-2021 Table H. Lundbeck Main Business Table H. Lundbeck Recent Development Figure Global Alzheimer’s Disease Therapeutics and Diagnostics Sales and Growth Rate (2016-2021) Figure Global Alzheimer’s Disease Therapeutics and Diagnostics Revenue and Growth Rate (2016-2021) Table Global Alzheimer’s Disease Therapeutics and Diagnostics Sales by Regions (2016-2021) Figure Global Alzheimer’s Disease Therapeutics and Diagnostics Sales Market Share by Regions in 2020 Table Global Alzheimer’s Disease Therapeutics and Diagnostics Revenue by Regions (2016-2021) Figure Global Alzheimer’s Disease Therapeutics and Diagnostics Revenue Market Share by Regions in 2020 Figure North America Alzheimer’s Disease Therapeutics and Diagnostics Sales and Growth Rate (2016-2021) Figure Europe Alzheimer’s Disease Therapeutics and Diagnostics Sales and Growth Rate (2016-2021) Figure China Alzheimer’s Disease Therapeutics and Diagnostics Sales and Growth Rate (2016-2021) Figure Japan Alzheimer’s Disease Therapeutics and Diagnostics Sales and Growth Rate (2016-2021) Figure Southeast Asia Alzheimer’s Disease Therapeutics and Diagnostics Sales and Growth Rate (2016-2021) Figure Other Regions Alzheimer’s Disease Therapeutics and Diagnostics Sales and Growth Rate (2016-2021) Table Global Alzheimer’s Disease Therapeutics and Diagnostics Sales by Big Type (2016-2021) Table Global Alzheimer’s Disease Therapeutics and Diagnostics Sales Market Share by Big Type (2016-2021) Figure Global Alzheimer’s Disease Therapeutics and Diagnostics Sales Market Share by Big Type in 2019 Table Global Alzheimer’s Disease Therapeutics and Diagnostics Revenue by Big Type (2016-2021) Table Global Alzheimer’s Disease Therapeutics and Diagnostics Revenue Market Share by Big Type (2016-2021) Table Global Alzheimer’s Disease Therapeutics and Diagnostics Revenue Market Share by Big Type in 2019 Figure Global Lumbar puncture test Sales Growth Rate (2016-2021) Figure Global Lumbar puncture test Price (2016-2021) Figure Global Computed tomography (CT) scan Sales Growth Rate (2016-2021) Figure Global Computed tomography (CT) scan Price (2016-2021) Figure Global Magnetic resonance imaging (MRI) Sales Growth Rate (2016-2021) Figure Global Magnetic resonance imaging (MRI) Price (2016-2021) Figure Global Electroencephalography (EEG) Sales Growth Rate (2016-2021) Figure Global Electroencephalography (EEG) Price (2016-2021) Figure Global Others Sales Growth Rate (2016-2021) Table Global Alzheimer’s Disease Therapeutics and Diagnostics Sales by Big Application (2016-2021) Table Global Alzheimer’s Disease Therapeutics and Diagnostics Sales Market Share by Big Application (2016-2021) Figure Global Alzheimer’s Disease Therapeutics and Diagnostics Sales Market Share by Big Application in 2019 Figure Global Marketed Drugs Sales Growth Rate (2016-2021) Figure Global Pipeline Drugs Sales Growth Rate (2016-2021) Figure Global Alzheimer’s Disease Therapeutics and Diagnostics Sales and Growth Rate (2021-2026) Figure Global Alzheimer’s Disease Therapeutics and Diagnostics Revenue and Growth Rate (2021-2026) Table Global Alzheimer’s Disease Therapeutics and Diagnostics Sales Forecast by Regions (2021-2026) Table Global Alzheimer’s Disease Therapeutics and Diagnostics Market Share Forecast by Regions (2021-2026) Figure North America Sales Alzheimer’s Disease Therapeutics and Diagnostics Market Forecast (2021-2026) Figure Europe Sales Alzheimer’s Disease Therapeutics and Diagnostics Market Forecast (2021-2026) Figure China Sales Alzheimer’s Disease Therapeutics and Diagnostics Market Forecast (2021-2026) Figure Japan Sales Alzheimer’s Disease Therapeutics and Diagnostics Market Forecast (2021-2026) Figure Southeast Asia Sales Alzheimer’s Disease Therapeutics and Diagnostics Market Forecast (2021-2026) Figure Other Regions Sales Alzheimer’s Disease Therapeutics and Diagnostics Market Forecast (2021-2026) Table Global Alzheimer’s Disease Therapeutics and Diagnostics Sales Forecast by Type (2021-2026) Table Global Alzheimer’s Disease Therapeutics and Diagnostics Market Share Forecast by Type (2021-2026) Table Global Alzheimer’s Disease Therapeutics and Diagnostics Sales Forecast by Application (2021-2026) Table Global Alzheimer’s Disease Therapeutics and Diagnostics Market Share Forecast by Application (2021-2026) Table Market Opportunities in Next Few Years Table Market Risks Analysis Table Market Drivers Figure Porter's Five Forces Analysis Table Macro Analysis of Upstream Markets Table Key Players in Upstream Markets Table Key Players of Upstream Markets Table Key Raw Materials Figure Price Trend of Key Raw Materials Table Key Suppliers of Raw Materials Figure Manufacturing Cost Structure of Alzheimer’s Disease Therapeutics and Diagnostics Table Macro Analysis of Down Markets Table Key Players in Down Markets Table Key Players of Downstream Markets Figure Sales Channel Figure North America Alzheimer’s Disease Therapeutics and Diagnostics Sales (K Units) Growth Rate Forecast (2020-2025) Figure North America Alzheimer’s Disease Therapeutics and Diagnostics Revenue (Million US$) Growth Rate Forecast (2020-2025) Figure Europe Alzheimer’s Disease Therapeutics and Diagnostics Sales (K Units) Growth Rate Forecast (2020-2025) Figure Europe Alzheimer’s Disease Therapeutics and Diagnostics Revenue (Million US$) Growth Rate Forecast (2020-2025) Figure Japan Alzheimer’s Disease Therapeutics and Diagnostics Production (K Units) Growth Rate Forecast (2020-2025) Figure Japan Alzheimer’s Disease Therapeutics and Diagnostics Revenue (Million US$) Growth Rate Forecast (2020-2025) Figure China Alzheimer’s Disease Therapeutics and Diagnostics Production (K Units) Growth Rate Forecast (2020-2025) Figure China Alzheimer’s Disease Therapeutics and Diagnostics Revenue (Million US$) Growth Rate Forecast (2020-2025) Figure Methodology/Research Approach Figure Market Size Estimation Figure Author List

Pfizer H. Lundbeck Forest Laboratories Eisai Johnson & Johnson. Novartis AC Immune TauRx Therapeutics